See if you qualify for our studies.
with alcohol abuse disorder
This double-blind, randomized study will evaluate the efficacy, safety and tolerability of ALKS 3831 in subjects with schizophrenia and alcohol use disorder (AUD). To qualify you must have experienced an acute exacerbation of schizophrenia within the past 6 months, have a diagnosis of schizophrenia and alcohol use disorder, and be 18 or older. Compensation for time and travel may be available.